Vitamin D and Statins Move Each Other's Blood Levels

Vitamin D and statins are among the most commonly taken things in the world, and plenty of people take both. They do interact, in both directions, and the effect is modest enough that it mostly matters for how you interpret a blood test.

A shared enzyme

Atorvastatin, simvastatin, and lovastatin are metabolised by CYP3A4, the liver enzyme responsible for clearing a large share of all prescription drugs. Vitamin D metabolism runs partly through the same enzyme, and 25(OH)D is itself a CYP3A4 substrate.

Two substances competing for one enzyme is the standard recipe for a pharmacokinetic interaction, and this pair follows it. The complication is that vitamin D also induces CYP3A4, increasing the amount of enzyme available, so the net effect is not a simple competition.

What has been observed

Patients started on atorvastatin have shown increases in serum 25(OH)D. The size of the increase varies across studies and the mechanism is not settled, but the direction has been consistent enough to be reported repeatedly.

Running the other way, vitamin D supplementation has been associated with lower atorvastatin concentrations in the blood, consistent with enzyme induction speeding up the drug’s clearance.

Neither finding has translated into a documented loss of cholesterol control or a safety signal, which is why this sits at the low end of the severity scale. The main practical consequence is interpretive: a 25(OH)D result taken shortly after starting a statin may read higher than the person’s underlying status, which matters if a supplement decision is being made off that number.

Not all statins are the same

Rosuvastatin and pravastatin are cleared largely through routes other than CYP3A4, so the shared-enzyme part of the story does not apply to them in the same way. Fluvastatin runs mainly through CYP2C9.

This is worth knowing because it means the interaction is drug specific rather than a property of the whole statin class, and swapping between statins can change whether it applies at all.

The muscle symptom question

There is a persistent hypothesis linking low vitamin D status to statin-associated muscle symptoms, the aching and weakness that leads some people to stop treatment. It is a plausible idea, since both vitamin D deficiency and statins can produce myalgia, and the two are easy to confuse.

The evidence has not settled it. Trials testing whether vitamin D supplementation reduces statin-associated muscle symptoms have produced mixed results, with the larger and better controlled ones tending toward no clear benefit. Anyone experiencing muscle symptoms on a statin has a conversation to have with their prescriber, and it is not one a supplement resolves.

Timing

No separation is needed. These effects operate through liver enzyme activity over days and weeks, not through anything happening in the stomach, so taking them at the same time or twelve hours apart makes no difference.

---

Reference

1. Office of Dietary Supplements, National Institutes of Health. "Vitamin D: Fact Sheet for Health Professionals." ods.od.nih.gov